Acadia Pharmaceuticals
John Van Johnston has a strong background in the pharmaceutical industry, with a focus on access, reimbursement, patient, and provider support. John Van has held various director-level positions at companies such as Acadia Pharmaceuticals Inc., Recordati Rare Diseases Inc., and Takeda. John joined Takeda through the acquisition of Shire and has experience in business development, sales training, and product management. John holds a BS in Finance and Psychology from San Diego State University and completed a Clerkship in Rheumatology at Stanford University.
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.